Product Information
CG 200745 is a histone protein-conjugate that inhibits the activity of mammalian target of rapamycin complex 1 (mTORC1) and specifically increases acetylation of the histones H3 and H4. This drug has been shown to have cardioprotective effects in a number of preclinical models, including cardiac hypertrophy and heart failure. CG 200745 also has anti-cancer effects when used in combination with other medicines. It has shown efficacy against cancer cells through inhibition of histone deacetylases (HDACs).
Chemical properties
Technical inquiry about: 3D-LMB22133 CG 200745
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.